Hepatocellular carcinoma (HCC) continues to be a serious medical problem with poor
prognosis worldwide. The distribution of the major etiologies of HCC is changing due to the …

Introduction Nonalcoholic fatty liver disease (NAFLD) is replacing viral hepatitis as the
leading cause of chronic liver disease and hepatocellular carcinoma (HCC) in many …

Simple Summary In this study, we demonstrated that overall 51.2% of patients with
hepatocellular carcinoma (HCC) had elevated alpha-fetoprotein (AFP) levels. The …

Background and aims We investigated the clinical impact of the newly defined metabolic-
associated fatty liver disease (MAFLD) in patients undergoing hepatectomy for HCC …

Background This systematic review and meta-analysis aimed to compare the outcomes of
curative therapy (resection, transplantation, ablation) for hepatocellular carcinoma (HCC) …

Introduction. A Noninvasive diagnosis model for digestive diseases is the vital issue for the
current clinical research. Our systematic review is aimed at demonstrating diagnosis …

Metabolic risk factors, such as obesity, fatty liver, high lipidemia, and diabetes mellitus are
associated with increased risk for nonviral hepatocellular carcinoma (HCC); however, few …

Background Adverse outcomes of cirrhosis remain a top priority. Aims We examined the
distribution of cirrhosis causes, HCC incidence and mortality and related changes over time …

During the progression from hepatitis to fibrosis, cirrhosis, and liver failure, the accumulation
of stressed/damaged hepatocyte elements associated with liver inflammation is critical. The …

Background The characteristics and prognosis of cryptogenic hepatocellular carcinoma
(HCC) remain unclear. The albumin-bilirubin (ALBI) grade and its updated version, the easy …